Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68788-4008

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68788-4008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin Calcium Tab Usp 10mg (Atorvastatin 10mg 90s Container Label)

Label for Atorvastatin Calcium Tablets USP 10 mg, a film-coated oral tablet generic for Lipitor. The label includes directions for use, storage instructions, and manufacturer information (MSN Laboratories Pvt. Ltd.). It also displays barcode and QR code elements, with sections for lot, batch, and expiration dates, plus bilingual instructions in English and Spanish. The labeler is Preferred Pharmaceuticals Inc.*

FDA Label Image

Atorvastatin-figure-01 (Atorvastatin Figure 01)

A line graph showing cumulative incidence (%) on the y-axis over time in years on the x-axis, comparing Atorvastatin and placebo. The graph features a continuous line for Atorvastatin and a dashed line for placebo, with the Atorvastatin line consistently lower. Statistical values HR=0.64 (0.50-0.83) and p=0.0005 are displayed on the chart.*

FDA Label Image

Atorvastatin-figure-02 (Atorvastatin Figure 02)

A line chart comparing cumulative hazard percentages over time (in years) between Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint through four years of follow-up, while the y-axis shows cumulative hazard percentage. The Atorvastatin group shows a lower hazard compared to placebo, with hazard ratio and p-value noted on the graph.*

FDA Label Image

Atorvastatin-figure-03 (Atorvastatin Figure 03)

A line graph comparing the percentage of subjects experiencing a cardiovascular event over five years for Atorvastatin 10 mg and 80 mg doses. The x-axis shows time to first major cardiovascular endpoint in years, and the y-axis shows percentage of subjects with events. The graph includes a hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and a p-value of 0.0002.*

FDA Label Image

Structure (Atorvastatin Structure)

Chemical structure of atorvastatin calcium dihydrate showing the molecular arrangement including phenyl groups, hydroxyl, and carboxyl functional groups coordinated with calcium ions and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.